Orforglipron ni iki?

Orforglipron ni diyabete yo mu bwoko bwa 2 hamwe nubuvuzi bwo kugabanya ibiro biri gutezwa imbere kandi biteganijwe ko bizahinduka umunwa kumiti yatewe inshinge. Ni iy'umuryango wa glucagon umeze nka peptide-1 (GLP-1) reseptor agonist kandi usa na Wegovy (Semaglutide) na Mounjaro (Tirzepatide). Ifite imirimo yo kugenzura isukari mu maraso, kugabanya ubushake bwo kurya no kongera guhaga, bityo bigafasha kugabanya ibiro hamwe n’isukari mu maraso.

Bitandukanye n’imiti myinshi ya GLP-1, inyungu yihariye ya Orforglipron iri muburyo bwayo bwa buri munsi aho kuba buri cyumweru cyangwa buri munsi. Ubu buryo bwubuyobozi bwazamuye cyane abarwayi kubahiriza no korohereza imikoreshereze, byerekana iterambere ryingenzi kubantu badakunda inshinge cyangwa bafite imyumvire yo kurwanya inshinge.

Mu bigeragezo bivura, Orforglipron yerekanye ingaruka nziza zo kugabanya ibiro. Amakuru yerekana ko abitabiriye gufata Orforglipron buri munsi mu byumweru 26 bikurikiranye bahuye nogutakaza ibiro 8% kugeza 12%, byerekana akamaro gakomeye mugucunga ibiro. Ibisubizo byatumye Orforglipron igira ibyiringiro bishya byo kuvura ejo hazaza h’indwara ya diyabete yo mu bwoko bwa 2 n'umubyibuho ukabije, kandi inerekana inzira y'ingenzi mu bijyanye n'imiti ya GLP-1, iva mu gutera inshinge ikajya mu kanwa.